Carlozzi, N. E.
Downing, N. R.
Schilling, S. G.
Lai, J.-S.
Goodnight, S. M.
Miner, J. A.
A. Frank, S.
Funding for this research was provided by:
National Institute of Neurological Disorders and Stroke (R01NS077946, R01NS040068)
National Center for Advancing Translational Sciences (UL1TR000433)
Center for Inherited Disease Research , NIH
CHDI Foundation
Article History
Accepted: 26 April 2016
First Online: 3 May 2016
Compliance with ethical standards
:
: Carlozzi, N.E. currently has research grants from the NIH; she is also supported by grant funding from the NIH, NIDILRR, and CHDI; she declares no conflicts of interest. Downing, N.R. declares no conflicts of interest. Schilling, S.G. has a research grant from NSF. He is also supported by grant funding from NIH. He declares no conflicts of interest. Lai J.-S. currently has research grants from the NIH; she declares no conflicts of interest. Goodnight, S.M. is supported by grant funding from the NIH and the Craig H. Neilsen Foundation; she declares no conflicts of interest. Miner, J.A. is supported by research grants from the NIH; she declares no conflict of interest. Frank, S. receives salary support from the Huntington Study Group for a study sponsored by Auspex Pharmaceuticals. There is no conflict of interest.
: All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and with the 1964 Helsinki Declaration and its later amendments or comparable ethical standards.
: Informed consent was obtained from all individual participants included in the study.